| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,586 |
3,927 |
$1.34M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,241 |
1,356 |
$953K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,128 |
2,635 |
$890K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,120 |
1,743 |
$419K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,321 |
848 |
$281K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
509 |
442 |
$155K |
| 70450 |
Computed tomography, head or brain; without contrast material |
427 |
363 |
$130K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
613 |
553 |
$129K |
| 80053 |
Comprehensive metabolic panel |
3,037 |
2,364 |
$50K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,872 |
755 |
$41K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,866 |
2,251 |
$30K |
| 71046 |
Radiologic examination, chest; 2 views |
1,219 |
1,099 |
$22K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
283 |
239 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
883 |
747 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,699 |
2,863 |
$15K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
30 |
28 |
$12K |
| 85027 |
|
2,081 |
1,740 |
$10K |
| 81025 |
|
119 |
103 |
$10K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
534 |
186 |
$8K |
| 84484 |
|
1,801 |
1,155 |
$8K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
23 |
14 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
103 |
79 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
18 |
17 |
$5K |
| G0378 |
Hospital observation service, per hour |
98 |
53 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,017 |
1,576 |
$4K |
| 81001 |
|
1,453 |
1,240 |
$4K |
| 83690 |
|
795 |
631 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,047 |
2,315 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
868 |
589 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,720 |
1,252 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
12 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
5,501 |
3,880 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
140 |
64 |
$1K |
| 85610 |
|
981 |
754 |
$1K |
| 82248 |
|
617 |
500 |
$1K |
| 83605 |
|
299 |
211 |
$1K |
| 82077 |
|
127 |
100 |
$928.63 |
| 83735 |
|
296 |
197 |
$716.44 |
| 97162 |
|
13 |
12 |
$696.92 |
| 71045 |
Radiologic examination, chest; single view |
510 |
405 |
$585.41 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
147 |
120 |
$542.32 |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,093 |
1,598 |
$451.27 |
| 81003 |
|
108 |
97 |
$409.72 |
| J3490 |
Unclassified drugs |
5,479 |
1,413 |
$337.88 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
990 |
587 |
$249.69 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,075 |
1,389 |
$201.57 |
| 84145 |
|
34 |
31 |
$169.91 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
19 |
14 |
$164.32 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
425 |
323 |
$158.78 |
| 84703 |
|
45 |
40 |
$157.80 |
| 84443 |
Thyroid stimulating hormone (TSH) |
14 |
12 |
$140.94 |
| J2704 |
Injection, propofol, 10 mg |
98 |
55 |
$127.48 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
535 |
306 |
$120.55 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,227 |
1,066 |
$117.78 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,071 |
770 |
$108.93 |
| 83880 |
|
16 |
14 |
$107.42 |
| 87040 |
|
23 |
12 |
$106.60 |
| 80047 |
|
18 |
16 |
$87.34 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
59 |
41 |
$34.16 |
| A9270 |
Non-covered item or service |
1,480 |
965 |
$0.35 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
58 |
51 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
96 |
80 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
26 |
24 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
40 |
36 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
71 |
54 |
$0.00 |
| 96376 |
|
25 |
13 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
27 |
14 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
15 |
13 |
$0.00 |